Author:
Haifer Craig,Leong Rupert W,Paramsothy Sudarshan
Funder
Janssen
Pfizer
Takeda
Ferring
Abbvie
Royal Australasian College of Physicians
Aspen
Celgene
Gilead
Hospira
MSD
Novartis
GESA
Endochoice
National Health and Medical Research Council of Australia
Shire
Emerge Health
Subject
Drug Discovery,Pharmacology
Reference55 articles.
1. Patient perceptions of fecal microbiota transplantation for ulcerative colitis;Kahn;Inflamm Bowel Dis,2013
2. Fecal microbiota transplantation: indications, methods, evidence, and future directions;Borody;Curr Gastroenterol Rep,2013
3. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis;Sood;J Gastroenterol Hepatol,2020
4. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection;Quraishi;Aliment Pharmacol Ther,2017
5. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice;Haifer;Gut,2020
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献